<DOC>
	<DOC>NCT01426139</DOC>
	<brief_summary>The objective of this clinical investigation is to assess the safety and clinical performance of the Orsiro Limus Eluting Stent System in Indian subjects with single de-novo coronary artery lesions.</brief_summary>
	<brief_title>BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Main Subject has provided a written informed consent Single de novo lesion with ≥ 50% and &lt;100% stenosis in up to 2 coronary arteries The target lesion length is ≤ 26 mm The target reference vessel diameter is ≥ 2.0 mm and ≤ 4.0 mm Main Evidence of myocardial infarction within 72 hours prior to index procedure Unprotected left main coronary artery disease (stenosis &gt;50%) Threevessel coronary artery disease at time of procedure Thrombus in target vessel Target lesion involves a side branch &gt; 2.0 mm in diameter Heavily calcified lesion Target lesion is located in or supplied by an arterial or venous bypass graft</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>